Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Zymeworks Inc.
< Previous
1
2
3
Next >
Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate Programs at EORTC-NCI-AACR Conference
Today 6:00 EDT
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks Reports Inducement Grant Under Nasdaq Stock Market Rule 5635(c)
September 03, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks Announces Participation in Upcoming Investor Conferences
August 22, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks Announces Share Repurchase Program of up to $60 Million of its Common Stock
August 01, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks Provides Corporate Update and Reports Second Quarter 2024 Financial Results
August 01, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks Announces Participation in Upcoming Investor Conferences
July 30, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks Appoints Leone Patterson as Chief Business and Financial Officer
July 25, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW191, a Novel Folate Receptor-⍺ Targeted Topoisomerase I Inhibitor Antibody-Drug Conjugate
July 22, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks To Report Second Quarter 2024 Financial Results and Host Conference Call on August 1, 2024
July 11, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cell Targeting Bispecific Antibody for Mesothelin-expressing Cancers
June 17, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks Announces China NMPA Acceptance of Biologics License Application for Zanidatamab for Second-Line Treatment of Biliary Tract Cancer
June 10, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks Announces Participation in Upcoming Investor Conferences
May 28, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results
May 02, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks Announces Participation in Upcoming Investor Conferences
April 30, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
April 11, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting
April 08, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors
March 28, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks Announces Participation in Upcoming Investor Conferences
March 27, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks Reports Fourth Quarter and Full Year 2023 Financial Results
March 06, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate and Multispecific Platforms at the American Association for Cancer Research Annual Meeting
March 05, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks Announces Participation in Upcoming Investor Conferences
February 27, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks To Host Fourth Quarter and Full Year 2023 Results Conference Call
February 14, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of Directors
February 08, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks Announces Participation in Upcoming Investor Conferences
January 31, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks Outlines Strategic Priorities and Outlook for 2024 and 2025
January 04, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks Announces Additional Leadership Appointments
January 04, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks Announces $50 Million Private Placement to EcoR1 Capital
December 26, 2023
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks Added to Nasdaq Biotechnology Index
December 15, 2023
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
NBI
ZYME
Zymeworks Announces Participation in Upcoming Investor Conference
November 30, 2023
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks Provides Corporate Update and Reports Third Quarter 2023 Financial Results
November 07, 2023
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.